Praxis Precision Medicines to Present at Cowen’s 42nd Annual Healthcare Conference

Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX) will participate in the Neuropsych panel at Cowen’s 42^nd Annual Healthcare Conference on March 7, 2022, at 9:10 a.m. ET. The event will be accessible via live webcast on the company's website, with a replay available for 30 days post-event. Praxis focuses on developing therapies for CNS disorders using genetic insights, addressing conditions such as epilepsy, psychiatric, and movement disorders. They currently have three clinical-stage product candidates.

BOSTON, March 01, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in the “Neuropsych” panel at Cowen’s 42^nd Annual Healthcare Conference on Monday, March 7, 2022 at 9:10 a.m. ET.

The panel will be available via live webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. A replay of the webcast will be available on Praxis’ website for 30 days following the event.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio with multiple programs, including product candidates across psychiatric disorders, movement disorders, epilepsy and other CNS indications, with three clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.

FAQ

When is the Cowen’s 42nd Annual Healthcare Conference participation by PRAX?

Praxis Precision Medicines will participate in the Cowen’s 42nd Annual Healthcare Conference on March 7, 2022, at 9:10 a.m. ET.

How can I watch the PRAX Neuropsych panel at the conference?

The Neuropsych panel featuring Praxis will be available via live webcast on the company's Investors + Media section of their website.

Will there be a replay of the PRAX panel at the conference?

Yes, a replay of the webcast will be available on the Praxis website for 30 days after the event.

What is the focus of Praxis Precision Medicines?

Praxis Precision Medicines focuses on developing therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance.

What types of disorders does PRAX address?

Praxis addresses various CNS disorders including epilepsy, psychiatric, and movement disorders through their genetic insights.